Titan Biotech has informed that the Board of Directors of the Company, at its meeting held on 02nd January, 2026 has approved and reconstituted the following Committees of the Board with effect from 02nd January, 2026: a) Reconstitution of the Audit Committee by appointing Brijesh Kumar Singh and Debendra Kumar Sabat as Member of the Committee with effective from 02nd January, 2026. Post reconstitution, the composition of the Audit Committee with effective from 02nd January, 2026. Details enclosed.
The above information is a part of company’s filings submitted to BSE.
